JN122
JN122, a spiroindoline-containing molecule, is a MDM2 inhibitor. JN122 Inhibits MDM2/p53 protein–protein interaction and exerts robust in vivo antitumor efficacy. JN122 has antiproliferative activity in HCT-116 cells and HEK-293 cells with IC50 values of 39.6 nM and 4.28μM, respectively. JN122 can promote activation of p53 and its target genes, inhibited cell cycle progression, and induced cell apoptosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3035577-19-3
- Fòrmula: C33H37Cl2N3O4
- Peso molecular:610.57
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
IC50: 39.6 nM (HCT-116 cells); 4.28μM (HEK-293 cells)[1].
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
2.9 nM
Compound: (-)60; JN122
|
Growth inhibition of human A549 cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human A549 cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| HCT-116 | IC50 |
<1 nM
Compound: (-)60; JN122
|
Antiproliferative activity against human HCT-116 cells harboring p53 assessed inhibition of cell growth incubated for 4 days by celltiter-glo assay
Antiproliferative activity against human HCT-116 cells harboring p53 assessed inhibition of cell growth incubated for 4 days by celltiter-glo assay
|
[PMID: 38062557] |
| HCT-116 | IC50 |
13.6 nM
Compound: XVI; JN122
|
Antiproliferative activity against human HCT-116 cells incubated for 4 days by CCK8 assay
Antiproliferative activity against human HCT-116 cells incubated for 4 days by CCK8 assay
|
[PMID: 38581730] |
| HeLa | IC50 |
12.24 nM
Compound: (-)60; JN122
|
Growth inhibition of human HeLa cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human HeLa cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| HepG2 | IC50 |
0.32 nM
Compound: (-)60; JN122
|
Growth inhibition of human HepG2 cells harboring p53 incubated for 4 days by celltiter glo assay
Growth inhibition of human HepG2 cells harboring p53 incubated for 4 days by celltiter glo assay
|
[PMID: 38062557] |
| MOLM-13 | IC50 |
49.9 nM
Compound: (-)60; JN122
|
Growth inhibition of human MOLM-13 cells incubated for 2 days by CCK-8 assay
Growth inhibition of human MOLM-13 cells incubated for 2 days by CCK-8 assay
|
[PMID: 38062557] |
| MOLM-13 | IC50 |
0.2 nM
Compound: XVI; JN122
|
Antiproliferative activity against human MOLM-13 cells incubated for 2 days by CCK8 assay
Antiproliferative activity against human MOLM-13 cells incubated for 2 days by CCK8 assay
|
[PMID: 38581730] |
| MSTO-211H | IC50 |
9.48 nM
Compound: (-)60; JN122
|
Growth inhibition of human MSTO-211H cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human MSTO-211H cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| NCI-H460 | IC50 |
0.26 nM
Compound: (-)60; JN122
|
Growth inhibition of human NCI-H460 cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human NCI-H460 cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| SW480 | IC50 |
7.1 nM
Compound: (-)60; JN122
|
Growth inhibition of human SW480 cells incubated for 4 days by CCK-8 assay
Growth inhibition of human SW480 cells incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
Chemical Information
-
No. CAS 3035577-19-3
-
Peso molecular 610.57
-
Fòrmula C33H37Cl2N3O4
-
SMILES
CCN1[C@H]([C@@H]([C@@]2([C@@H]1CC(C)(C)C)CNC3=CC(Cl)=CC=C32)C4=CC(Cl)=CC=C4)C(NC5=CC=C(C=C5OC)C(O)=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)